Herein, we designed lipid‐polymer hybrid nanoparticles by a combinational assembly strategy for compartmentalized Cas9‐ and STAT3‐targeting sgRNA (sgSTAT3) delivery to knock out STAT3 for tumor vessel normalization and immunostimulatory reprogramming in glioblastoma (Scheme1). This evidence concerns the gene STAT3 and neoplasm.